Most likely, the existence of a NF1-MAPK-FOSL1 axis goes beyond GBM pathogenesis since FOSL1 appears to be upregulated in concomitance with NF1 mutations in multiple tumor types (Figure 8—figure supplement 1). This evidence concerns the gene FOSL1 and glioblastoma.